Faculty profile
Rakesh Kumar
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Research
Latest papers
A Novel Host-Based Immunotherapy for the Suppression of HBV and HCV Replication: Heat-Killed Caulobacter crescentus (HKCC).
Cells · 2026
Host-directed broad-spectrum immunotherapeutic strategy for respiratory infections: Heat-killed Caulobacter crescentus (HKCC) as an innate-immune based biotherapeutic/postbiotic.
PLoS pathogens · 2026
ESAT-6-derived lipopeptide-based mucosal vaccine elicits distinct humoral immune responses concomitant with a reduction in mycobacterium infection.
Emerging microbes & infections · 2026
Latest funding
- $680,850
Studies on novel influenza A virus inhibitors
CIHR · 2018 · Nominated PI
- $668,940
Studies on novel anti-tuberculosis agents
CIHR · 2016 · Nominated PI
- $159,850
Development of novel chemotherapeutics for tuberculosis
CIHR · 2013 · Nominated PI
43 publications.
A Novel Host-Based Immunotherapy for the Suppression of HBV and HCV Replication: Heat-Killed Caulobacter crescentus (HKCC).
Patel RS, Gupta N, Vedi S, Kumar R, Agrawal B
Host-directed broad-spectrum immunotherapeutic strategy for respiratory infections: Heat-killed Caulobacter crescentus (HKCC) as an innate-immune based biotherapeutic/postbiotic.
Werellagama S, Patel RS, Gupta N, Vedi S, Duque D, Bavananthasivam J, Kumar R, Tran A, Agrawal B
ESAT-6-derived lipopeptide-based mucosal vaccine elicits distinct humoral immune responses concomitant with a reduction in mycobacterium infection.
Werellagama S, Gupta N, Li J, Kumar R, Agrawal B
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.
Patel RS, Duque D, Bavananthasivam J, Hewitt M, Sandhu JK, Kumar R, Tran A, Agrawal B
Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic.
Gupta N, Vedi S, Garg S, Loo E, Li J, Kunimoto DY, Kumar R, Agrawal B
Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds.
Garg S, Kumar R, Kunimoto D, Rayat GR
Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.
Agrawal B, Gupta N, Vedi S, Singh S, Li W, Garg S, Li J, Kumar R
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N, Garg S, Vedi S, Kunimoto DY, Kumar R, Agrawal B
New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
Gupta N, Kumar R, Agrawal B
Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.
Agrawal B, Singh S, Gupta N, Li W, Vedi S, Kumar R
Studies on novel influenza A virus inhibitors
Principal investigators: Kumar, Rakesh
Keywords: Chemotherapeutic Agents; Drug Synthesis; Drug Therapy; Drug, Design And Discovery; In Vitro And In Vivo Studies; Medicinal Chemistry; Pharmaceutical Sciences; Pharmaceuticals
Studies on novel anti-tuberculosis agents
Principal investigators: Kumar, Rakesh
Keywords: Antimicrobials; Chemotherapeutic Agents; Drug Design And Development; Infectious Disease; Mouse Models; Mycobacteria; Pharmaceutical Science; Tuberculosis
Development of novel chemotherapeutics for tuberculosis
Principal investigators: Kumar, Rakesh
Keywords: Antimycobacterial; Chemotherapeutic Agents; Nucleosides; Tuberculosis
Novel cross-protective (universal) vaccine for influenza infections
Principal investigators: Agrawal, Babita
Keywords: Conserved Antigen; Influenza; Tlr Agonists; Universal Vaccine
Development of new class of antiviral drugs for influenza A virus infections
Principal investigators: Kumar, Rakesh
Keywords: Antiviral; Chemotherapeutic Agents; Influenza A Virus; Nucleosides; Rna Polymerase
Studies on new antiviral (hepatitis B virus) agents
Principal investigators: Kumar, Rakesh
Keywords: Anti-Hepatitis Agents; Antiviral Agents; Chemotherapeutics; Dna Virus; Drug Design Discovery; Drug Synthesis; Drug Therapy; Mechanism Of Action
Studies on novel anti-tuberculosis agents
Principal investigators: Kumar, Rakesh
Keywords: Antibacterial Drugs; Antimicrobial Agents; Chemotherapeutic Agents; Drug Therapy; Infectious Disease; Medicinal Chemistry
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Rakesh Kumar and Babita Agrawal: 32 shared papers
- Amogh Agrawal and Rakesh Kumar: 2 shared papers
- Amogh Agrawal and Babita Agrawal: 1 shared paper
- Laboratory Medicine and Pathology
- Surgery
- Medicine
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.